Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Inhaled Nitric Oxide Market: By Application: Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Inhaled Nitric Oxide Market Outlook
The global inhaled nitric oxide market stood at a value of around USD 684.6 million in 2021. The market is further expected to grow at a CAGR of 8.1% in the forecast period of 2022-2027 to attain USD 1,092.5 million by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Product Utilisation in Neonatal Respiratory Treatment to Bolster the Growth of the Inhaled Nitric Oxide Industry
Based on application, the neonatal respiratory treatment segment accounts for a significant share in the market and is anticipated to witness a considerable growth in the forecast period. The growth of this segment can be attributed to the rising cases of pulmonary hypertension, neonatal hypoxic respiratory failure, and new born respiratory distress syndrome, among others. In this regard, nitric oxide dilates and relaxes the muscle tension and dilates blood vessels, which leads to proper absorption of oxygen in the body. Additionally, inhaled nitric oxide also reduces the need for extracorporeal membrane oxygenation in infants suffering from persistent pulmonary hypertension. Over the forecast period, the growing cases of breathing problems among geriatrics are likely to augment the growth of the inhaled nitric oxide industry.
The Asia Pacific to Account for a Significant Share of the Inhaled Nitric Oxide Industry
The inhaled nitric oxide industry in the Asia Pacific is driven by the growing birth rate in countries like India, China, Pakistan, and Bangladesh, among others. The growing prevalence of hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis among the geriatric population in the region is likely to augment the market growth in the forecast period. The market is estimated to be further supplemented by the growing cases of breathing problems among the population, owing to the rising levels of air pollution worldwide.
Inhaled Nitric Oxide: Market Segmentation
Inhaled nitric oxide is defined as a selective pulmonary vasodilator, which regulates the muscle tone and treats hypoxemic respiratory failure among the newly born infants by improving ventilation-perfusion mismatch. It is used along with a breathing machine for the treatment of respiratory ailments such as COPD and ARDS.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on application, the market is segmented into:
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Use of the Product in the Healthcare Sector to Boost the Growth of the Inhaled Nitric Oxide Industry
The global inhaled nitric oxide industry is being driven by its growing application in the healthcare sector. The product has witnessed a significant surge in adoption by hospitals, ambulatory surgical centres, and advanced clinics, owing to the growing incidences of fatalities caused by respiratory ailments. The market is anticipated to be positively influenced by the changing patient preference towards minimally-invasive treatments and the growing healthcare expenditure in the emerging economies of the world. The market is estimated to be further supported by the growing cases of neonatal hypoxic respiratory failure. In addition, the rising air pollution levels worldwide are further leading to the growing incidences of respiratory diseases, especially among the geriatric population, which is estimated to support the market growth in the forecast period.
Key Industry Players in the Global Inhaled Nitric Oxide Market
The report gives a detailed analysis of the following key players in the global inhaled nitric oxide market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Bellerophon Therapeutics Inc.
- Air Liquide Group
- BOC Limited
- Vero Biotech, LLC
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2021 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, Region |
| Breakup by Application | Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, Vero Biotech, LLC, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Inhaled Nitric Oxide Market Analysis
8.1 Key Industry Highlights
8.2 Global Inhaled Nitric Oxide Historical Market (2017-2021)
8.3 Global Inhaled Nitric Oxide Market Forecast (2022-2027)
8.4 Global Inhaled Nitric Oxide Market by Application
8.4.1 Neonatal Respiratory Treatment
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Chronic Obstructive Pulmonary Disease (COPD)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Acute Respiratory Distress Syndrome (ARDS)
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Others
8.5 Global Inhaled Nitric Oxide Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Bellerophon Therapeutics Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Air Liquide Group
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 BOC Limited
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Vero Biotech, LLC
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry News and Development
List of Key Figures and Tables
1. Global Inhaled Nitric Oxide Market: Key Industry Highlights, 2017 and 2027
2. Global Inhaled Nitric Oxide Historical Market: Breakup by Application (USD Million), 2017-2021
3. Global Inhaled Nitric Oxide Market Forecast: Breakup by Application (USD Million), 2022-2027
4. Global Inhaled Nitric Oxide Historical Market: Breakup by Region (USD Million), 2017-2021
5. Global Inhaled Nitric Oxide Market Forecast: Breakup by Region (USD Million), 2022-2027
6. North America Inhaled Nitric Oxide Historical Market: Breakup by Country (USD Million), 2017-2021
7. North America Inhaled Nitric Oxide Market Forecast: Breakup by Country (USD Million), 2022-2027
8. Europe Inhaled Nitric Oxide Historical Market: Breakup by Country (USD Million), 2017-2021
9. Europe Inhaled Nitric Oxide Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Asia Pacific Inhaled Nitric Oxide Historical Market: Breakup by Country (USD Million), 2017-2021
11. Asia Pacific Inhaled Nitric Oxide Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Latin America Inhaled Nitric Oxide Historical Market: Breakup by Country (USD Million), 2017-2021
13. Latin America Inhaled Nitric Oxide Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Middle East and Africa Inhaled Nitric Oxide Historical Market: Breakup by Country (USD Million), 2017-2021
15. Middle East and Africa Inhaled Nitric Oxide Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Global Inhaled Nitric Oxide Market Structure
Key Questions Answered in the Report
In 2021, the global inhaled nitric oxide market attained a value of nearly USD 684.6 million.
The market is estimated to grow at a CAGR of 8.1% between 2022 and 2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 1,092.5 million by 2027.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the industry, such as the rising cases of breathing problems among the geriatrics and new born babies, growing adoption of the product in hospitals, surgical centres and clinics, changing patient preference towards minimally-invasive treatments, and rising healthcare expenditure in the emerging economies are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing application of inhaled nitric oxide in the healthcare industry and the rapid technological advancements.
Neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS), among others are the major applications of the product.
The major players in the industry are Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, and Vero Biotech, LLC, among others.
Analyst Review
The global inhaled nitric oxide market attained a value of USD 684.6 million in 2021, driven by the rising cases of breathing problems among the geriatrics and new born babies. Aided by the growing patient inclination towards minimally-invasive treatments, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 8.1%. The market is projected to reach USD 1,092.5 million by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The significant applications of the product include neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS), among others. The major regional markets for inhaled nitric oxide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bellerophon Therapeutics Inc., Air Liquide Group, BOC Limited, and Vero Biotech, LLC, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The India sexual wellness market is driven by the increasing sexual liberation among the young population. Aided by the proliferation of various start-ups and direct-to-consumer (D2C) brands of sexual...
The atopic dermatitis treatment market attained a value of USD 9.67 billion in 2021, driven by the rising inclination towards renewable energy sources and carbon emission control. Aided by the growing...
The Europe compression bandages market attained a value of nearly USD 398.11 million in 2021, driven by the rising prevalence of acute injuries, such as sprains and strains, and diseases like lymphede...
The global bone and joint health ingredients market attained a value of USD 3.26 billion in 2021, driven by rising healthcare awareness, especially among the ageing population. Aided by the growing ph...
The global human papillomavirus (HPV) vaccine market attained a value of nearly USD 4.2 billion in 2021, driven by the increasing awareness about human papillomavirus. Aided by the growing demand for ...
NEWSLETTER